The formulation of clinical pharmacy practice guidelines in China: status and development_Chinese Journal of Evidence-Based Medicine

Authors：

ZHOU Pengxiang ^1,2 , ZHANG Xianglin ³ ,  ZHAI Suodi ^1,2

1. Department of Pharmacy, Peking University Third Hospital, Beijing 100191, P.R.China;
2. Institute for Drug Evaluation, Peking University Health Science Center, Beijing 100191, P.R.China;
3. Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, P.R.China;

Corresponding author：

ZHAI Suodi, Email: zhaisuodi@163.com

Keywords：

Clinical practice guideline; Clinical pharmacy; Status; Development

DOI：

10.7507/1672-2531.202105038

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Clinical pharmacy practice guidelines have developed rapidly in recent years. They provide a series of recommendations for optimizing drug treatment management and improving pharmaceutical care appropriateness and are widely employed in clinical practice. Based on literature review and the experience of guideline development, this paper summarized the meaning, formulation methods, formulation status, and registration of clinical pharmacy practice guidelines, and provided suggestions for the development of guidelines.

Citation： ZHOU Pengxiang, ZHANG Xianglin, ZHAI Suodi. The formulation of clinical pharmacy practice guidelines in China: status and development. Chinese Journal of Evidence-Based Medicine, 2021, 21(9): 993-997. doi: 10.7507/1672-2531.202105038 Copy

1.	IOM. Clnical practice guidelines we can trust. Washington, DC: The National Academic Press, 2011.
2.	国家卫生健康委员会. 关于加快药学服务高质量发展的意见. 国家卫生健康委员会公报, 2018, (11): 16-18.
3.	赵荣生, 杨毅恒, 杨丽, 等. 新型冠状病毒感染: 医院药学工作指导与防控策略专家共识. 中国药学杂志, 2020, 55(4): 268-277.
4.	陈耀龙, 罗旭飞. 临床实践指南的制订方法与步骤. 中华传染病杂志, 2019, 37(9): 523-526.
5.	中国医院协会, 国家儿童医学中心, 国家感染性疾病医疗质量控制中心, 等. 抗病毒药物在儿童病毒感染性呼吸道疾病中的合理应用指南. 中华实用儿科临床杂志, 2020, 35(19): 1441-1450.
6.	Ye Z, Rochwerg B, Wang Y, et al. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ, 2020, 192(20): E536-E545.
7.	李晓桐, 翟所迪, 王育琴, 等. 《严重过敏反应急救指南》推荐意见. 药物不良反应杂志, 2019, 21(2): 85-91.
8.	首都医科大学附属北京胸科医院, 中国防痨协会临床试验专业分会, 《中国防痨杂志》编辑委员会. 环丝氨酸治疗结核病的临床用药指南. 中国防痨杂志, 2020, 42(6): 533-540.
9.	王小琴, 陈耀龙, 杨楠, 等. 快速建议指南及其制定方法介绍. 中国循证医学杂志, 2015, 15(9): 1103-1105.
10.	孙鑫, 李玲, 李舍予, 等. 促进高质量临床实践指南快速制订与有效使用: MAGIC体系与中国行动. 中国循证医学杂志, 2020, 20(1): 2-6.
11.	母义明, 翟所迪. 基于肠促胰素治疗药物临床应用的快速建议指南. 中华内分泌代谢杂志, 2016, 32(6): 448-454.
12.	Zhou P, Wang X, Zhang X, et al. Recommendations on off-label use of intravenous azithromycin in children. Int J Clin Pract, 2021, 75(7): e14010.
13.	李慧博, 门鹏, 王宇, 等. 《人血白蛋白用于肝硬化治疗的快速建议指南》解读. 临床药物治疗杂志, 2018, 16(12): 10-16.
14.	张相林, 缪丽燕, 陈文倩. 治疗药物监测工作规范专家共识(2019版). 中国医院用药评价与分析, 2019, 19(8): 897-898, 902.
15.	黄亮, 张伶俐, 李幼平, 等. 国内外治疗药物监测指南现状的循证研究. 中国循证医学杂志, 2016, 16(4): 451-459.
16.	中国药理学会治疗药物监测研究专业委员会, 中国药学会循证药学专业委员会. 治疗药物监测指南的制订指南. 中国循证医学杂志, 2021, 21(2): 125-132.
17.	Ye ZK, Chen YL, Chen K, et al. Therapeutic drug monitoring of vancomycin: a guideline of the division of therapeutic drug monitoring, Chinese pharmacological society. J Antimicrob Chemother, 2016, 71(11): 3020-3025.
18.	Chen K, Zhang X, Ke X, et al. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, chinese pharmacological society. Ther Drug Monit, 2018, 40(6): 663-674.
19.	He N, Su S, Ye Z, et al. Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological society. Clin Infect Dis, 2020, 71(Suppl 4): S363-S371.
20.	林夏, 杨克虎, 陈耀龙, 等. 中国临床实践指南的现状与思考. 中国循证医学杂志, 2017, 17(5): 497-500.
21.	赵明娟, 靳英辉, 张菁, 等. 临床实践指南制定方法-利益冲突的声明和管理. 中国循证心血管医学杂志, 2018, 10(5): 513-517.
22.	Brouwers MC, Kerkvliet K, Spithoff K, et al. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ, 2016, 352: i1152.
23.	Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.

1. IOM. Clnical practice guidelines we can trust. Washington, DC: The National Academic Press, 2011.
2. 国家卫生健康委员会. 关于加快药学服务高质量发展的意见. 国家卫生健康委员会公报, 2018, (11): 16-18.
3. 赵荣生, 杨毅恒, 杨丽, 等. 新型冠状病毒感染: 医院药学工作指导与防控策略专家共识. 中国药学杂志, 2020, 55(4): 268-277.
4. 陈耀龙, 罗旭飞. 临床实践指南的制订方法与步骤. 中华传染病杂志, 2019, 37(9): 523-526.
5. 中国医院协会, 国家儿童医学中心, 国家感染性疾病医疗质量控制中心, 等. 抗病毒药物在儿童病毒感染性呼吸道疾病中的合理应用指南. 中华实用儿科临床杂志, 2020, 35(19): 1441-1450.
6. Ye Z, Rochwerg B, Wang Y, et al. Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline. CMAJ, 2020, 192(20): E536-E545.
7. 李晓桐, 翟所迪, 王育琴, 等. 《严重过敏反应急救指南》推荐意见. 药物不良反应杂志, 2019, 21(2): 85-91.
8. 首都医科大学附属北京胸科医院, 中国防痨协会临床试验专业分会, 《中国防痨杂志》编辑委员会. 环丝氨酸治疗结核病的临床用药指南. 中国防痨杂志, 2020, 42(6): 533-540.
9. 王小琴, 陈耀龙, 杨楠, 等. 快速建议指南及其制定方法介绍. 中国循证医学杂志, 2015, 15(9): 1103-1105.
10. 孙鑫, 李玲, 李舍予, 等. 促进高质量临床实践指南快速制订与有效使用: MAGIC体系与中国行动. 中国循证医学杂志, 2020, 20(1): 2-6.
11. 母义明, 翟所迪. 基于肠促胰素治疗药物临床应用的快速建议指南. 中华内分泌代谢杂志, 2016, 32(6): 448-454.
12. Zhou P, Wang X, Zhang X, et al. Recommendations on off-label use of intravenous azithromycin in children. Int J Clin Pract, 2021, 75(7): e14010.
13. 李慧博, 门鹏, 王宇, 等. 《人血白蛋白用于肝硬化治疗的快速建议指南》解读. 临床药物治疗杂志, 2018, 16(12): 10-16.
14. 张相林, 缪丽燕, 陈文倩. 治疗药物监测工作规范专家共识(2019版). 中国医院用药评价与分析, 2019, 19(8): 897-898, 902.
15. 黄亮, 张伶俐, 李幼平, 等. 国内外治疗药物监测指南现状的循证研究. 中国循证医学杂志, 2016, 16(4): 451-459.
16. 中国药理学会治疗药物监测研究专业委员会, 中国药学会循证药学专业委员会. 治疗药物监测指南的制订指南. 中国循证医学杂志, 2021, 21(2): 125-132.
17. Ye ZK, Chen YL, Chen K, et al. Therapeutic drug monitoring of vancomycin: a guideline of the division of therapeutic drug monitoring, Chinese pharmacological society. J Antimicrob Chemother, 2016, 71(11): 3020-3025.
18. Chen K, Zhang X, Ke X, et al. Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, chinese pharmacological society. Ther Drug Monit, 2018, 40(6): 663-674.
19. He N, Su S, Ye Z, et al. Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological society. Clin Infect Dis, 2020, 71(Suppl 4): S363-S371.
20. 林夏, 杨克虎, 陈耀龙, 等. 中国临床实践指南的现状与思考. 中国循证医学杂志, 2017, 17(5): 497-500.
21. 赵明娟, 靳英辉, 张菁, 等. 临床实践指南制定方法-利益冲突的声明和管理. 中国循证心血管医学杂志, 2018, 10(5): 513-517.
22. Brouwers MC, Kerkvliet K, Spithoff K, et al. The AGREE reporting checklist: a tool to improve reporting of clinical practice guidelines. BMJ, 2016, 352: i1152.
23. Chen Y, Yang K, Marušic A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med, 2017, 166(2): 128-132.

Previous Article
Method to draw conclusions from a network meta-analysis: a partially contextualised framework
Next Article
Initiative of evidence-based practice in response to public health emergencies

Chinese Journal of Evidence-Based Medicine

The formulation of clinical pharmacy practice guidelines in China: status and development

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content